EsoCap selected as a top drug discovery and development provider by Pharma Tech Outlook

EsoCap AG has been recognised by Pharma Tech Outlook as a top drug discovery and development solution provider in Europe for 2020.

“We are extremely pleased to have been chosen for the cover page of Pharma Tech Outlook, among the top 10 companies that are at the forefront of providing drug discovery and development solutions and transforming businesses”, said Isabelle Racamier, EsoCap AG CEO, “This acknowledgement strengthens our resolve to bring a major improvement to the lives of patients using EsoCap’s highly promising and innovative technology”.

Read full PDF of post release here

Read full PDF of Pharma Tech Outlook excerpt on EsoCap here

EsoCap’s Profile on Pharma Tech Outlook website